Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: A phase 1, open-label, dose-escalation study

Anas Younes, Joseph M. Connors, Steven I. Park, Michelle Fanale, Megan M. O'Meara, Naomi N. Hunder, Dirk Huebner, Stephen M. Ansell

Research output: Contribution to journal › Article › peer-review

211 Scopus citations

Fingerprint

Dive into the research topics of 'Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: A phase 1, open-label, dose-escalation study'. Together they form a unique fingerprint.

Medicine & Life Sciences